Andrew Callos, EVP, Chief Commercial Officer at CYTOKINETICS INC (CYTK), sold 3,639 shares at $65.00 ($237K) on 2026-03-31, disclosed to the SEC on 2026-03-31.
Seasonal sale ($237k) by EVP, Chief Commercial Officer — this insider has traded CYTK in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| CYTK | SELL | 2026-07-02 | $1.3M | — | Filing → |
| CYTK | SELL | 2026-06-01 | $1.1M | — | Filing → |
| CYTK | SELL | 2026-05-05 | $875K | — | Filing → |